LOGIN  |  REGISTER
Cue Biopharma
C4 Therapeutics

Addus HomeCare to Participate in March Investor Conferences

March 11, 2025 | Last Trade: US$111.33 13.28 13.55

FRISCO, Texas / Mar 11, 2025 / Business Wire / Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the following investor conferences:

  • Oppenheimer 35th Annual Healthcare MedTech & Services Conference on Tuesday, March 18, 2025. Members of the management team will participate in a virtual discussion at 12:00 p.m. Eastern Time / 11:00 a.m. Central Time on Tuesday, March 18, 2025.
  • KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025. Members of the management team will participate in a virtual fireside chat discussion at 3:00 p.m. Eastern Time / 2:00 p.m. Central Time on Wednesday, March 19, 2025.

In connection with the virtual conferences, there will be a live broadcast and replay of the Company’s presentation available under the Investor Relations section of the Company’s website, www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately one hour following the conclusion of the live broadcast.

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 62,000 consumers through 257 locations across 23 states. For more information, please visit www.addus.com.

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page